Related Experiment Video
Updated: Jun 18, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Hypoxic-ischemic encephalopathy in the term infant
Ali Fatemi1, Mary Ann Wilson, Michael V Johnston
1Kennedy Krieger Institute, Department of Neurology, Johns Hopkins Medical Institutions, 707 N Broadway, Baltimore, MD 21205, USA.
Insights
Perinatal hypoxia-ischemia causes cerebral palsy. Researchers identified molecular mechanisms and potential therapeutic targets for hypoxic-ischemic encephalopathy, but treatments remain limited.
Area of Science:
- Neuroscience
- Pediatrics
- Molecular Biology
Background:
- Perinatal hypoxia-ischemia is a leading cause of cerebral palsy and childhood disabilities.
- Significant research advances in understanding hypoxic-ischemic encephalopathy (HIE) over the past two decades.
- Current therapeutic interventions for HIE remain limited despite identified molecular mechanisms.
Purpose of the Study:
- To review molecular pathways implicated in perinatal hypoxia-ischemia.
- To discuss potential therapeutic targets for HIE based on recent molecular discoveries.
Main Methods:
- Literature review of recent research on hypoxia-ischemia.
- Analysis of identified molecular mechanisms in HIE.
- Discussion of potential therapeutic strategies.
Main Results:
- Several key molecular pathways involved in the pathophysiology of hypoxia-ischemia have been elucidated.
- New insights into the complex biological processes underlying HIE.
- Identification of several promising molecular targets for future therapeutic development.
Conclusions:
- Despite advances in understanding HIE molecular mechanisms, effective treatments are still lacking.
- Targeting identified molecular pathways offers potential for novel therapeutic interventions.
- Further research is needed to translate molecular findings into clinical practice for HIE.
Abstract:
Hypoxia-ischemia in the perinatal period is an important cause of cerebral palsy and associated disabilities in children. There has been significant research progress in hypoxic-ischemic encephalopathy over the last 2 decades, and many new molecular mechanisms have been identified. Despite all these advances, therapeutic interventions are still limited. In this article the authors discuss several molecular pathways involved in hypoxia-ischemia, and potential therapeutic targets.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hepatic Encephalopathy
Cytotoxic Edema: Pathophysiology
Encephalitis l: Introduction
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
